_256_384.png)
News | November 19, 2025
Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening
India presents one of the world’s largest untapped opportunities for neurovascular screening
India presents one of the world’s largest untapped opportunities for neurovascular screening
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
The partnership aims to develop novel, selective small molecules targeting TDP-43 pathology
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
OERIS offers extended antiemetic coverage through a single injection that effectively prevents both acute and delayed CINV for up to five days
Subscribe To Our Newsletter & Stay Updated
